restarting tirzepatide after 3 weeks Mounjaro a Break: Dosing and What to Expect Restarting Tirzepatide After a 4-Week

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix

This gives your GI system time to adapt to the slowed gastric emptying

It is administered as a 16 mg subcutaneous implant every 2 months

Generation I Semaglutide GLP-1 only Peak Weight Loss 14.9% STEP 1 trial 68 weeks Receptor Coverage Single GLP-1 FDA Status Approved (Wegovy, 2021) FIRST PUBLISHED Wilding et al., NEJM 2021 Generation II Tirzepatide GLP-1 + GIP Peak Weight Loss 22.5% SURMOUNT-1 trial 72 weeks Receptor Coverage Dual GLP-1, GIP FDA Status Approved (Zepbound, 2023) First Published Jastreboff et al., NEJM 2022 Generation III Retatrutide GLP-1 + GIP + GCGR Peak Weight Loss 24.2% Phase 2 48 weeks (highest dose) Receptor Coverage Triple GLP-1, GIP, GCGR FDA Status Phase 3 (TRIUMPH program) First Published Jastreboff et al., NEJM 2023 -SELECTED LITERATURE Key Retatrutide research and clinical publications

Self-Administered Injections: Remedy Meds provides weight loss injections that clients can administer themselves, with detailed instructions on proper use to ensure safety and effectiveness